Prospective cohort study to assess the performance of tools to describe the Natural History of CytoMegaloVirus infection and transmission in FAMILIes with children attending daycare centers in France (CMV FAMILI study)

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS1000001054
• Study ID:
  1000001054
• Official title and acronym:
  Prospective cohort study to assess the performance of tools to describe the Natural History of CytoMegaloVirus infection and transmission in FAMILIes with children attending daycare centers in France (CMV FAMILI study)
• DARWIN EU® study:
  No
• Study countries:
  France
• Study description:
  The primary objective of this study is to assess the performance of polymerase chain reaction (PCR)-based case definition criteria for identifying primary cytomegalovirus (CMV) infection in parents/caregivers who are CMV-seronegative at baseline.
• Study status:
  Planned

Research institutions and networks

Institutions

Merck Sharp & Dohme LLC

United States

Study timelines

Date when funding contract was signed

Actual:29/01/2026

Study start date

Planned:01/09/2026

Data analysis start date

Planned:01/09/2029

Date of final study report

Planned:31/03/2030

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Merck Sharp & Dohme LLC

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable